Claritev EBITDA Margin 2019-2025 | CTEV

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Claritev (CTEV) over the last 10 years. The current EBITDA margin for Claritev as of March 31, 2025 is .
Claritev EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.93B $-0.44B -47.84%
2024-12-31 $0.93B $-0.94B -101.29%
2024-09-30 $0.94B $-0.86B -91.40%
2024-06-30 $0.96B $-0.49B -50.89%
2024-03-31 $0.96B $0.07B 6.98%
2023-12-31 $0.96B $0.60B 62.27%
2023-09-30 $0.96B $-0.06B -6.26%
2023-06-30 $0.97B $-0.07B -6.94%
2023-03-31 $1.02B $0.00B -0.29%
2022-12-31 $1.08B $0.06B 5.84%
2022-09-30 $1.14B $0.80B 69.98%
2022-06-30 $1.17B $0.85B 72.74%
2022-03-31 $1.16B $0.85B 72.93%
2021-12-31 $1.12B $0.81B 72.61%
2021-09-30 $1.07B $0.65B 60.24%
2021-06-30 $1.01B $0.34B 33.76%
2021-03-31 $0.94B $0.27B 28.48%
2020-12-31 $0.94B $0.27B 28.89%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.605B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.136B 58.95
Hims & Hers Health (HIMS) United States $12.000B 124.67
Tempus AI (TEM) United States $10.868B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $4.068B 63.55
Hinge Health (HNGE) United States $3.121B 0.00
Privia Health (PRVA) United States $2.805B 191.75
Enovis (ENOV) United States $1.818B 10.14
Schrodinger (SDGR) United States $1.741B 0.00
Clover Health Investments (CLOV) United States $1.567B 0.00
Phreesia (PHR) United States $1.501B 0.00
Omnicell (OMCL) United States $1.466B 25.86
Azenta (AZTA) United States $1.310B 60.89
10x Genomics (TXG) United States $1.150B 0.00
Fulgent Genetics (FLGT) United States $0.648B 0.00
Butterfly Network (BFLY) United States $0.591B 0.00
Talkspace (TALK) United States $0.553B 165.25
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Outset Medical (OM) United States $0.342B 0.00
Health Catalyst (HCAT) United States $0.275B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.130B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.45
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00